IDEAS home Printed from https://ideas.repec.org/p/aiz/louvar/2018042.html
   My bibliography  Save this paper

Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations: a monocentric prospective phase II study

Author

Listed:
  • Hammer, Jennifer
  • Seront, Emmanuel
  • Duez, Steven
  • Dupont, Sophie
  • Van Damme, An
  • Schmitz, Sandra
  • Hoyoux, Claire

Abstract

No abstract is available for this item.

Suggested Citation

  • Hammer, Jennifer & Seront, Emmanuel & Duez, Steven & Dupont, Sophie & Van Damme, An & Schmitz, Sandra & Hoyoux, Claire, 2018. "Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations: a monocentric prospective phase II study," LIDAM Reprints ISBA 2018042, Université catholique de Louvain, Institute of Statistics, Biostatistics and Actuarial Sciences (ISBA).
    • Handle: RePEc:aiz:louvar:2018042
    Note: In : Orphanet journal of rare diseases, vol. 13, no.1, p. 191 (2018)
    as

    Download full text from publisher

    To our knowledge, this item is not available for download. To find whether it is available, there are three options:
    1. Check below whether another version of this item is available online.
    2. Check on the provider's web page whether it is in fact available.
    3. Perform a search for a similarly titled item that would be available.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Patricio Vargas & Carolina Whittle & Francisca Recule & Ximena Fajre, 2019. "New Use of Rapamycin Stent in Non-Responding Facial Lymphatic Malformation," Biomedical Journal of Scientific & Technical Research, Biomedical Research Network+, LLC, vol. 18(4), pages 13737-13740, June.
    2. Sandra Schrenk & Lindsay J. Bischoff & Jillian Goines & Yuqi Cai & Shruti Vemaraju & Yoshinobu Odaka & Samantha R. Good & Joseph S. Palumbo & Sara Szabo & Damien Reynaud & Catherine D. Raamsdonk & Ric, 2023. "MEK inhibition reduced vascular tumor growth and coagulopathy in a mouse model with hyperactive GNAQ," Nature Communications, Nature, vol. 14(1), pages 1-20, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:aiz:louvar:2018042. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Nadja Peiffer (email available below). General contact details of provider: https://edirc.repec.org/data/isuclbe.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.